Petr Kastner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petr Kastner has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jiří Klimeš
Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
9 shared publications - Věra Klimešová
Charles University in Prague
7 shared publications - Eva Snejdrova
Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
2 shared publications Jan Kresta
2 shared publications- Karel Palát
Charles University in Prague
2 shared publications - Pavla Pilarova2 shared publications
Latest Publications
- 12 April 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 199, 114282
Formulation study of PLGA in situ films for topical delivery of salicylates
- 12 April 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 199, 114282
Formulation study of PLGA in situ films for topical delivery of salicylates
- 20 April 2020
- Published by Wiley in Acta Physiologica
- Vol. 229 (4) , e13478
Serotonin homeostasis in the materno‐foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO‐A) in uptake and degradation of serotonin by human and rat term placenta
Aim: Serotonin is crucial for proper foetal development, and the placenta has been described as a ‘donor’ of serotonin for the embryo/foetus. However, in later stages of gestation the foetus produces its own serotonin from maternally‐derived tryptophan and placental supply is no longer needed. We propose a novel model of serotonin homeostasis in the term placenta with special focus on the protective role of organic cation transporter 3 (OCT3/SLC22A3).Methods: Dually perfused rat term placenta was employed to quantify serotonin/tryptophan transport and metabolism. Placental membrane vesicles isolated from human term placenta were used to characterize serotonin transporters on both sides of the syncytiotrophoblast.Results: We obtained the first evidence that serotonin is massively taken up from the foetal circulation by OCT3. This uptake is concentration‐dependent and inhibitable by OCT3 blockers of endogenous (glucocorticoids) or exogenous (pharmaceuticals) origin. Population analyses in rat placenta revealed that foetal sex influences placental extraction of serotonin from foetal circulation. Negligible foetal serotonin levels were detected in maternal‐to‐foetal serotonin/tryptophan transport and metabolic studies.Conclusion: We demonstrate that OCT3, localized on the foetus‐facing membrane of syncytiotrophoblast, is an essential component of foeto‐placental homeostasis of serotonin. Together with serotonin degrading enzyme, monoamine oxidase‐A, this offers a protective mechanism against local vasoconstriction effects of serotonin in the placenta. However, this system may be compromised by OCT3 inhibitory molecules, such as glucocorticoids or antidepressants. Our findings open new avenues to explore previously unsuspected/unexplained complications during pregnancy including prenatal glucocorticoid excess and pharmacotherapeutic risks of treating pregnant women with OCT3 inhibitors.
- 20 April 2020
- Published by Wiley in Acta Physiologica
- Vol. 229 (4) , e13478
Serotonin homeostasis in the materno‐foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO‐A) in uptake and degradation of serotonin by human and rat term placenta
Aim: Serotonin is crucial for proper foetal development, and the placenta has been described as a ‘donor’ of serotonin for the embryo/foetus. However, in later stages of gestation the foetus produces its own serotonin from maternally‐derived tryptophan and placental supply is no longer needed. We propose a novel model of serotonin homeostasis in the term placenta with special focus on the protective role of organic cation transporter 3 (OCT3/SLC22A3).Methods: Dually perfused rat term placenta was employed to quantify serotonin/tryptophan transport and metabolism. Placental membrane vesicles isolated from human term placenta were used to characterize serotonin transporters on both sides of the syncytiotrophoblast.Results: We obtained the first evidence that serotonin is massively taken up from the foetal circulation by OCT3. This uptake is concentration‐dependent and inhibitable by OCT3 blockers of endogenous (glucocorticoids) or exogenous (pharmaceuticals) origin. Population analyses in rat placenta revealed that foetal sex influences placental extraction of serotonin from foetal circulation. Negligible foetal serotonin levels were detected in maternal‐to‐foetal serotonin/tryptophan transport and metabolic studies.Conclusion: We demonstrate that OCT3, localized on the foetus‐facing membrane of syncytiotrophoblast, is an essential component of foeto‐placental homeostasis of serotonin. Together with serotonin degrading enzyme, monoamine oxidase‐A, this offers a protective mechanism against local vasoconstriction effects of serotonin in the placenta. However, this system may be compromised by OCT3 inhibitory molecules, such as glucocorticoids or antidepressants. Our findings open new avenues to explore previously unsuspected/unexplained complications during pregnancy including prenatal glucocorticoid excess and pharmacotherapeutic risks of treating pregnant women with OCT3 inhibitors.
- 6 April 2017
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 13 (3) , 250-255
Stability Indicating Method for Determination of Sodium Picosulfate in Pharmaceutical Preparation – Comparison of HPLC, UHPLC and HTLC
Background: Various chromatographic modes were used for the evaluation of liquid pharmaceutical preparation containing favorite laxative drug sodium picosulfate. Objective: The aim of this study was to compare capabilities of conventional HPLC, UHPLC and HTLC on the example of stability indicating methods with UV 263 nm detection for simultaneous determination of sodium picosulfate, its two degradation products and sodium benzoate in oral liquid pharmaceutical preparation. Method: A novel money-saving preparation of system suitability test solution using partial acid hydrolysis yielding main degradation products was developed. Developed HPLC system with RP-C18e column used acetonitrile – propan-2-ol - phosphate puffer pH 7.0 with addition of cetyltrimethylammonium bromide (43:2:55, v/v/v) as mobile phase, 1 ml/min, column temperature 40 °C. UHPLC separation was carried out using core-shell RP-C18 column under the same chromatographic conditions, flow-rate 0.5 ml/min. HTLC method used the same column as in UHPLC, mobile phase acetonitrile - 30 mM triethylamine phosphate buffer pH 5.0 (10:90, v/v), flow-rate 0.5 ml/min and column temperature 100 °C. Results: HPLC method was very reliable and robust but rather time consuming, whereas UHPLC brought 5times faster analysis with 10times lower solvent consumption. High temperature during HTLC separation did not affect the stability of the tested compounds, and organic solvents consumption was 8times lower. Conclusion: Although all developed methods were satisfactorily validated, UHPLC is the most suitable technique for routine analysis or stability studies.
- 6 April 2017
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 13 (3) , 250-255
Stability Indicating Method for Determination of Sodium Picosulfate in Pharmaceutical Preparation – Comparison of HPLC, UHPLC and HTLC
Background: Various chromatographic modes were used for the evaluation of liquid pharmaceutical preparation containing favorite laxative drug sodium picosulfate. Objective: The aim of this study was to compare capabilities of conventional HPLC, UHPLC and HTLC on the example of stability indicating methods with UV 263 nm detection for simultaneous determination of sodium picosulfate, its two degradation products and sodium benzoate in oral liquid pharmaceutical preparation. Method: A novel money-saving preparation of system suitability test solution using partial acid hydrolysis yielding main degradation products was developed. Developed HPLC system with RP-C18e column used acetonitrile – propan-2-ol - phosphate puffer pH 7.0 with addition of cetyltrimethylammonium bromide (43:2:55, v/v/v) as mobile phase, 1 ml/min, column temperature 40 °C. UHPLC separation was carried out using core-shell RP-C18 column under the same chromatographic conditions, flow-rate 0.5 ml/min. HTLC method used the same column as in UHPLC, mobile phase acetonitrile - 30 mM triethylamine phosphate buffer pH 5.0 (10:90, v/v), flow-rate 0.5 ml/min and column temperature 100 °C. Results: HPLC method was very reliable and robust but rather time consuming, whereas UHPLC brought 5times faster analysis with 10times lower solvent consumption. High temperature during HTLC separation did not affect the stability of the tested compounds, and organic solvents consumption was 8times lower. Conclusion: Although all developed methods were satisfactorily validated, UHPLC is the most suitable technique for routine analysis or stability studies.
- 17 March 2016
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 42 (10) , 1653-1659
Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir
Commercially available antibacterial semisolid preparations intended for topical application provide only short-term drug release. A sustained kinetics is possible by exploitation of a biodegradable polymer carrier. The purpose of this work is to formulate a mucoadhesive system with aciclovir (ACV) based on a solid molecular dispersion of this drug in poly(lactic-co-glycolic acid) branched on tripenterythritol (PLGA/T). The ACV incorporation into PLGA/T was carried out either by solvent method, or melting method, or plasticization method using various plasticizers. The drug–polymer miscibility, plasticizer efficiency and content of residual solvent were found out employing DSC. Viscosity was measured at the shear rate range from 0.10 to 10.00 s−1 at three temperatures and data were analyzed by Newtonian model. The mucoadhesive properties were ascertained in the tensile test on a mucin substrate. The amount of ACV released was carried out in a wash-off dissolution test. The DSC results indicate a transformation of crystalline form of ACV into an amorphous dissolved in branched polyester carrier, and absence of methyl formate residuals in formulation. All the tested plasticizers are efficient at Tg depression and viscosity decrease. The non-conventional ethyl pyruvate possessing supportive anti-inflammatory activity was evaluated as the most suitable plasticizer. The ACV release was strongly dependent on the ethyl pyruvate concentration and lasted from 1 to 10 days. The formulated PLGA/T system with aciclovir exhibits increased adhesion to mucosal hydrophilic surfaces and prolonged ACV release controllable by degradation process and viscosity parameters.
- 17 March 2016
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 42 (10) , 1653-1659
Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir
Commercially available antibacterial semisolid preparations intended for topical application provide only short-term drug release. A sustained kinetics is possible by exploitation of a biodegradable polymer carrier. The purpose of this work is to formulate a mucoadhesive system with aciclovir (ACV) based on a solid molecular dispersion of this drug in poly(lactic-co-glycolic acid) branched on tripenterythritol (PLGA/T). The ACV incorporation into PLGA/T was carried out either by solvent method, or melting method, or plasticization method using various plasticizers. The drug–polymer miscibility, plasticizer efficiency and content of residual solvent were found out employing DSC. Viscosity was measured at the shear rate range from 0.10 to 10.00 s−1 at three temperatures and data were analyzed by Newtonian model. The mucoadhesive properties were ascertained in the tensile test on a mucin substrate. The amount of ACV released was carried out in a wash-off dissolution test. The DSC results indicate a transformation of crystalline form of ACV into an amorphous dissolved in branched polyester carrier, and absence of methyl formate residuals in formulation. All the tested plasticizers are efficient at Tg depression and viscosity decrease. The non-conventional ethyl pyruvate possessing supportive anti-inflammatory activity was evaluated as the most suitable plasticizer. The ACV release was strongly dependent on the ethyl pyruvate concentration and lasted from 1 to 10 days. The formulated PLGA/T system with aciclovir exhibits increased adhesion to mucosal hydrophilic surfaces and prolonged ACV release controllable by degradation process and viscosity parameters.
- 22 March 2013
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 5 (10) , 2610-2614
Development and validation of rapid UHPLC method for determination of aciclovir, its impurities and preservatives in topical cream
The aim of this study was to develop a new, rapid and sensitive method for simultaneous determination of aciclovir, three related substances and two preservatives methyl and propyl parahydroxybenzoates present in topical cream. This important active substance, aciclovir is the drug of the first choice for treatment of Herpes viral infections. Pharmacological mechanism is inhibition of replication of viral particles. Its major related substances are guanine, diguanine and diacetylaciclovir and they all were evaluated in this study. Preparation of the cream samples was very rapid and consisted of dissolution, sonication and filtration through membrane filter 0.22 μm. Innovative and expanding UHPLC method was chosen for proper analysis due to its excellent separation efficiency and resolution. Binary gradient flow was optimized to a C18 chromatographic column (100 mm × 3.5 mm, 1.7 μm). 0.1 M ammonium acetate buffer pH 5.5 and acetonitrile–water–tetrahydrofuran (90 : 6 : 4, v/v/v) were used as mobile phases in gradient mode with flow rate of 0.5 ml min−1. Separation temperature was increased to rarely used 60 °C. Wavelength of UV detector was set to 254 nm. This effective method was validated in accordance with ICH guidelines. Linearity, precision, accuracy, specificity, robustness, detection and quantitation limits were evaluated. The significance of the developed method is based on the analysis of important active substance aciclovir, its impurities and preservative in pharmaceutical preparation using UHPLC system with relatively high separation temperature which leads to radical analysis time shortening up to five times and solvent saving up to ten times comparing to the conventional HPLC system using 5 μm particle packed analytical column.
- 22 March 2013
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 5 (10) , 2610-2614
Development and validation of rapid UHPLC method for determination of aciclovir, its impurities and preservatives in topical cream
The aim of this study was to develop a new, rapid and sensitive method for simultaneous determination of aciclovir, three related substances and two preservatives methyl and propyl parahydroxybenzoates present in topical cream. This important active substance, aciclovir is the drug of the first choice for treatment of Herpes viral infections. Pharmacological mechanism is inhibition of replication of viral particles. Its major related substances are guanine, diguanine and diacetylaciclovir and they all were evaluated in this study. Preparation of the cream samples was very rapid and consisted of dissolution, sonication and filtration through membrane filter 0.22 μm. Innovative and expanding UHPLC method was chosen for proper analysis due to its excellent separation efficiency and resolution. Binary gradient flow was optimized to a C18 chromatographic column (100 mm × 3.5 mm, 1.7 μm). 0.1 M ammonium acetate buffer pH 5.5 and acetonitrile–water–tetrahydrofuran (90 : 6 : 4, v/v/v) were used as mobile phases in gradient mode with flow rate of 0.5 ml min−1. Separation temperature was increased to rarely used 60 °C. Wavelength of UV detector was set to 254 nm. This effective method was validated in accordance with ICH guidelines. Linearity, precision, accuracy, specificity, robustness, detection and quantitation limits were evaluated. The significance of the developed method is based on the analysis of important active substance aciclovir, its impurities and preservative in pharmaceutical preparation using UHPLC system with relatively high separation temperature which leads to radical analysis time shortening up to five times and solvent saving up to ten times comparing to the conventional HPLC system using 5 μm particle packed analytical column.
- 1 February 2013
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 39, 61-64
Study of hydrophobic properties of biologically active open analogues of flavonoids
- 1 February 2013
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 39, 61-64
Study of hydrophobic properties of biologically active open analogues of flavonoids
- 1 December 2008
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 21 (6) , 465-468
Isolation and identification of amphetamines in urine by thin-layer chromatography
- 1 December 2008
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 21 (6) , 465-468
Isolation and identification of amphetamines in urine by thin-layer chromatography
- 1 December 2005
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 18 (106) , 450-454
Reversed-phase thin-layer chromatographic determination of the lipophilicity of potential antituberculotic compounds
- 1 December 2005
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 18 (106) , 450-454
Reversed-phase thin-layer chromatographic determination of the lipophilicity of potential antituberculotic compounds
- 1 January 2004
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 27 (16) , 2539-2545
Reversed‐Phase High Performance Liquid Chromatographic Determination of Lipophilicity of Potential Antituberculosis Compounds
- 1 January 2004
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 27 (16) , 2539-2545
Reversed‐Phase High Performance Liquid Chromatographic Determination of Lipophilicity of Potential Antituberculosis Compounds
- 1 April 2003
- Vol. 58 (4) , 242-4
HPLC assay in plasma and preliminary pharmacokinetic study of a quinazolinone derivative with spasmolytic effect.
An analytical method for analysis of 3-(o-bromo)-phenyl-2-(2',3'-dihydroxypropylthio)-4(3H)-quinazolinone from rat plasma using HPLC with reversed phase C18 and liquid-liquid extraction was developed. This method was used for a pharmacokinetic study in rat.
- 1 April 2003
- Vol. 58 (4) , 242-4
HPLC assay in plasma and preliminary pharmacokinetic study of a quinazolinone derivative with spasmolytic effect.
An analytical method for analysis of 3-(o-bromo)-phenyl-2-(2',3'-dihydroxypropylthio)-4(3H)-quinazolinone from rat plasma using HPLC with reversed phase C18 and liquid-liquid extraction was developed. This method was used for a pharmacokinetic study in rat.